FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals will focus on issues of interest to regulatory and investigative toxicologists and discuss new technologies and strategies that are being used to improve, reduce, and/or replace animal testing (3Rs). The conference also will have presentations on computational analysis and artificial intelligence (AI). For example, new technologies will need to be developed to meet the computational challenges that genomics poses for the near future—given highly distributed data acquisition that involves heterogeneous formats—as well as emerging opportunities for data reduction and real-time analysis.

The FutureTox series focuses on building the road for 21st-century toxicology and risk assessment practices, utilizing in vitro data and in silico models for predictive toxicology, and taking the high-throughput risk assessment paradigm forward to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making.

10-11 May, 2022

More information:
https://www.toxicology.org/events/shm/cct/FutureToxV.asp